The present invention may be further understood with reference to the following description and to the appended drawings, wherein like elements are referred to with the same reference numerals. The present invention relates to devices for ablating tissue within a hollow organ using RF energy.
Embodiments of the present invention are designed to overcome or minimize limitations of conventional ablation systems. According to the invention, a foam insert is inserted into the uterus, or in another body cavity to be treated, with an outer surface thereof in contact with target tissue. For example, a surface of the foam insert may be placed in contact with the endometrial lining. The foam insert may be shaped as desired to ensure contact with the target tissue while minimizing contact with non-targeted tissues. The foam insert may then be saturated with a fluid such as saline so that the fluid is in contact with those portions of target tissue which are in contact with an outer surface of the foam insert.
Once the foam insert and the fluid are in place within the body cavity, the fluid is used to convey energy to the target tissue. For example, a conventional RF generator (not shown) is electrically coupled to the foam insert to convey the RF energy thereto which is then conducted by the saline through the foam insert to the portions of target tissue contacting the foam insert to heat and ablate the target portions of the inner surfaces of the body cavity. As would be understood by those skilled in the art, a conventional RF generator may be used to generate the energy required to heat the tissue to achieve the desired degree of ablation. The transmission of energy from the external generator to the fluid may be enhanced or facilitated by the use of an energy receptor placed in the fluid or in the foam insert. For example, an antenna may be embedded in a body of the foam insert to more efficiently transfer RF energy to the fluid saturating the foam insert.
As shown in
The shape of the foam insert 102 is preferably tailored to bring the portions of the foam insert 102 saturated with the fluid 120 into contact only with desired portions of the lining 108 of the uterus which portions include target tissue to be treated. For example, the foam insert 102 may be shaped so that contacting portions 118 of an outer surface thereof touch target portions of the uterus lining 108 while other portions 119 of the outer surface of the foam insert 102 are spaced from the lining 108. In the exemplary embodiment, the foam insert 102 is placed into the uterus 106 via the vaginal canal 114 and the cervical opening 110. As would be understood by those skilled in the art, this procedure may be carried out minimally invasively using a hysteroscope to minimize discomfort and complications. The foam insert 102 may be delivered in place within the uterus 106 via a tube 112 that is inserted through the cervical opening 110.
Prior to the insertion, the foam insert 102 is compressed into a small insertion shape that allows it to fit through the tube 112. After being pushed out of the tube 112, the foam insert 102 expands to the operative shape shown in
The shape of the foam insert 102 may also change as the fluid 120 saturates the fluid retaining material 104. For example, soaking the fluid retaining material 104 with saline solution may substantially increase the volume of the foam insert 102 while a certain amount of deformation may also take place as the material of the foam insert 102 becomes saturated with saline. The shape and construction of the dry foam insert 102 is therefore selected to compensate for changes that take place as saline is added to the fluid retaining material 104 so that the shape, once saturated, is the desired operative shape with dimensions selected to place the first portions 118 of the outer surface of the foam insert 102 in contact with the target portions of tissue.
The fluid retaining material 104 of the foam insert 102 is selected to ensure that the fluid 120 is distributed substantially uniformly through the foam insert 102, or more specifically, substantially uniformly through the contacting portions 118. A substantially uniform distribution of the fluid 120 promotes uniformity in the depth of the lesions formed in the portions of the uterine lining 108 adjacent to the contacting portions 118. As described above, the fluid may be a saline solution, or any other biocompatible fluid with appropriate electrically conductive properties. The saline solution may conductivity, so any open-celled foam, e.g., PVA foam, may be utilized with the present invention. The saline is received within the foam insert 102 and help at the desired locations (i.e., the contacting portions 118) during the ablation procedure, rather than flowing freely within the uterine cavity 106. As a result, less fluid 120 is used as compared to procedures where the fluid is free flowing and the procedure may be completed more rapidly. While the system according to the present invention retains most of the saline within a confined volume, it places the fluid in contact with target tissue more effectively than is possible with conventional ablation methods that use fluids confined in bags or tubes.
The efficiency of the system 100 may be enhanced by including an energy receptor within the material of the foam insert 102. For example, as shown in
In addition, an optional handle 150 may be formed in the foam insert 102, to facilitate manipulation of the foam insert 102 during insertion into the target body cavity. For example, the antenna 152 may include an elongated component extending out of the foam insert 102 that forms the handle 150. As would be understood by those skilled in the art, the handle 150 is preferably sized and shaped for handling by a physician to position the foam insert 102 in a desired location within the uterus 106. Alternatively, a separate handle may be embedded in the material of the foam insert 102, or may be attached thereon prior to placement of the device.
According to a first embodiment of the invention, the fluid retaining material is exposed as an outer surface of the foam insert 102 at least at the contacting portions 118 to place the fluid 120 in direct contact with the inner lining 108 of the uterus 106. However, in a different embodiment, a lining or outer lining 122 may be applied to the surface 118 to achieve certain results. For example, the lining 122 may enhance the durability of the foam insert 102. The lining 122 may also confer other desirable properties to the foam insert 102. For example, the lining 122 may enhance the lubricity of the foam insert 102 to facilitate insertion into a body cavity or medical compounds may be included in the lining 122 to aid in the treatment of the target tissue, to aid in the healing of the tissue surrounding the treated tissue, or to protect non-targeted tissue. Additives, e.g., surfactants, may be utilized in the foam-making process to regulate pore size and make the outer lining 122 porous when the foam piece is molded.
An exemplary embodiment of a foam insert 304 according to the present invention was tested on a slab of animal tissue (beef liver) to determine its effectiveness as an RF electrode.
A subsequent test run was carried out to build on the results described above. In this run, a round foam insert was used, and the power was initially set to a high level of about 80 Watts. The device was run for 3 minutes, followed by 1 minute and then by 2 minutes runs. The shape and the size of the foam insert 304 were also optimized, by using a circular shape, and later by reducing the size of the electrode. The ablation region remained circular in these latter tests, and the size and depth of the lesion increased.
The present invention has been described with reference to specific exemplary embodiments. Those skilled in the art will understand that changes may be made in details, particularly in matters of shape, size, material and arrangement of parts. Accordingly, various modifications and changes may be made to the embodiments. For example, the exemplary devices described may be used to perform ablations of the lining in other bodily cavities or hollow organs other than the uterus. The specifications and drawings are, therefore, to be regarded in an illustrative rather than a restrictive sense.
This application claims the priority to the U.S. Provisional Application Ser. No. 60/841,416, entitled “Uterine Foam Insert for Ablation,” filed Aug. 31, 2006. The specification of the above-identified application is incorporated herewith by reference.
Number | Date | Country | |
---|---|---|---|
60841416 | Aug 2006 | US |